InvestorsHub Logo
Followers 17
Posts 811
Boards Moderated 0
Alias Born 02/21/2011

Re: None

Monday, 08/10/2015 8:33:36 AM

Monday, August 10, 2015 8:33:36 AM

Post# of 32544

PositiveID Selected to Present and Exhibit at the 2015 Military Health System Research Symposium August 17-20
PositiveID Corporation
1 minute ago
GlobeNewswire

????

Related Quotes

PSID0.0254-5.93%

PositiveID Corporation
Watchlist
0.0254-0.0016(-5.93%)
OTC MarketsFri, Aug 7, 2015 3:58 PM EDT

POSITIVEID CORP Financials EDGAR Online Financials 2 mths ago
10-Q for PositiveID Corp. Company Spotlight 2 mths ago

More

DELRAY BEACH, Fla., Aug. 10, 2015 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (PSID), a developer of biological detection and diagnostics solutions, announced today that it has been selected to present a poster and exhibit at the 2015 Military Health System Research Symposium (MHSRS) Conference on August 17-20, 2015, at the Marriott Harbor Beach Resort in Fort Lauderdale, FL. PositiveID will showcase its biological detection and diagnostics products, primarily its Firefly Dx, during the conference in Booth #50.

The Company’s poster, “Firefly Dx; Point-Of-Care Infectious Disease Detection and Diagnostics,” describes the development of the handheld, point-of-care (POC) diagnostics system for rapid identification of naturally occurring infectious diseases within 20 minutes. The Firefly Dx system uses assay specific, disposable cartridges in conjunction with a handheld device, and is designed to be a cost-effective diagnostic tool capable of easy and rapid onsite analysis against multiple user-defined pathogenic targets of interest.

Firefly Dx is designed to provide real-time, accurate diagnostic results in a handheld device, thereby leading to treatment scenarios at the point of need that are not possible with existing systems, which require lab-based equipment and can take hours or even days to provide results. Firefly's applications include point-of-need, lab-quality, detection of pathogenic organisms; agricultural and food screening in both domestic sectors and developing countries; and detection of biological agents associated with weapons of mass destruction.

The MHSRS is the Department of Defense’s premier scientific meeting. It is a venue for communicating and discussing new scientific knowledge resulting from military-unique research and development. It is the only military or civilian meeting that focuses specifically on the unique medical needs of the Warfighter.

The MHSRS provides a scholarly forum for the planning and development of future studies aimed at optimizing care for members of the Uniformed Services in operational settings. Held in a collaborative, joint setting, it enables military medical care providers with deployment experience to exchange information with Department of Defense and academic scientists, international partners, and industry on research and related health care initiatives falling under the topic areas of Combat Casualty Care, Military Operational Medicine, Clinical and Rehabilitative Medicine, and Military Infectious Disease. Its goal is to maximize research synergy among all of the branches of military service, while acknowledging the need for service-specific medical capabilities.

The MHSRS is an annual event that is sponsored by the Assistant Secretary of Defense for Health Affairs.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.